Dearborn Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $229K | Hold |
|
|||||
|
2024
Q4 | $212K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $337K | Sell |
|
|||||
|
2023
Q4 | $425K | Sell |
|
|||||
|
2023
Q3 | $503K | Sell |
|
|||||
|
2023
Q2 | $571K | Buy |
|
|||||
|
2023
Q1 | $557K | Sell |
|
|||||
|
2022
Q4 | $686K | Buy |
|
|||||
|
2022
Q3 | $593K | Sell |
|
|||||
|
2022
Q2 | $662K | Buy |
|
|||||
|
2022
Q1 | $613K | Buy |
|
|||||
|
2021
Q4 | $504K | Sell |
|
|||||
|
2021
Q3 | $627K | Sell |
|
|||||
|
2021
Q2 | $723K | Buy |
|
|||||
|
2021
Q1 | $643K | Buy |
|
|||||
|
2020
Q4 | $619K | Buy |
|
|||||
|
2020
Q3 | $593K | Buy |
|
|||||
|
2020
Q2 | $561K | Buy |
|
|||||
|
2020
Q1 | $475K | Buy |
|
|||||
|
2019
Q4 | $463K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $234K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $271K | Sell |
|
|||||
|
2016
Q1 | $241K | Hold |
|
|||||
|
2015
Q4 | $259K | Hold |
|
|||||
|
2015
Q3 | $223K | Sell |
|
|||||
|
2015
Q2 | $258K | Sell |
|
|||||
|
2015
Q1 | $294K | Hold |
|
|||||
|
2014
Q4 | $269K | Sell |
|
|||||
|
2014
Q3 | $237K | Hold |
|
|||||
|
2014
Q2 | $224K | Sell |
|
|||||
|
2014
Q1 | $254K | Sell |
|
|||||
|
2013
Q4 | $395K | Sell |
|
|||||
|
2013
Q3 | $417K | Buy |
|
|||||
|
2013
Q2 | $403K | Buy |
|